EU Lists Rare Nerve Disorder As Possible Side-Effect Of AstraZeneca COVID-19 Vaccine

EU Lists Rare Nerve Disorder As Possible Side-Effect Of AstraZeneca COVID-19 Vaccine

Europe’s medicines regulator has added an extremely rare nerve-damaging disorder, Guillain-Barr syndrome, as a possible side-effect of AstraZeneca’s COVID-19 vaccine, regular safety updates from the watchdog showed. The European Medicines Agency said a causal relationship between GBS and the AstraZeneca shot, known as Vaxzevria, was a “at least a reasonable possibility” after 833 cases of GBS were reported out of 592 million doses of the vaccine given worldwide by July 31.

Read more on CDE News

Latest News

Social partners discuss ESF+

July 17, 2021

Gozo’s first Reverse Osmosis is expected to become operational by the end of the year

June 30, 2021

Stefan Zrinzo Azzopardi

Malta Welcomes Council Approval For Digital Green Certificate

April 23, 2021

Rural roads in Qrendi get facelift through EU funds

April 13, 2021

Valletta Balconies Regneration

Three projects in favour of improving the life of Valletta residents

April 8, 2021

Commission opens new Erasmus+ application

April 6, 2021

Most enterprises that have benefitted from European funds intend to apply for more funding

March 18, 2021

EU European Commission Building News

Malta Gets €244 Million From The EU’s SURE Funds To Protect Jobs And Businesses

March 17, 2021

Malta Prime Minister European Union Flags Auberge de Castille

€2.8 Million In European Funds For Malta For The Implementation Of Policy Reforms And Capacity Building

March 2, 2021

This was created and maintained with the financial support of the European Union. Its contents are the sole responsibility of and do not necessarily reflect the views of the European Union